NCHR testimony at FDA about Clinical Trial Criteria for Interstitial Cystitis and Bladder Pain Syndrome

December 7, 2017. There is a need for new treatment options for interstitial cystitis and bladder pain syndrome (IC/BPS). These conditions have a range of causes and symptoms, and symptoms can be very similar to other conditions. This variation adds complexity to testing new treatments.  To meet the needs of patients, the FDA must hold the sponsors’ clinical trials to a high standard that ensures safe and effective treatments.

Read More »

NCHR Comments to HHS on Religious Exemptions and Contraceptives

December 5, 2017. We strongly oppose the IFR’s use of religious objections to undermine essential health care for millions of women in our country. The HHS must ensure the health of all our citizens by implementing policies based on sound medical and public health science. We urge that HHS bring evidenced-based practice into the forefront of health policies, as it has for decades.

Read More »
Page 10 of 65« First...89101112...203040...Last »